A Path to Insulin Independence: "The End of the Beginning".
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27058933.
- Also identified by DOI 10.1016/j.stem.2016.03.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Widespread application of β cell replacement to obtain insulin independence in people with type 1 diabetes requires an unlimited source of insulin-producing cells and the ability to block the pathological immune response. Recent reports in Nature Medicine and Nature Biotechnology present a creative bioengineering strategy for achieving these goals.
Medical subject headings
- Bioengineering
- Diabetes Mellitus, Type 1
- Insulin
- Insulin-Secreting Cells